This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
What drives stock market index performance includes macro trends, earnings, and valuation shifts. This overview explains the main forces behind movements.
27,569 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
When Occidental Petroleum faced a retreat in stock price, traders asked whether it was a one-off event or a signal. T...
Exxon's decision to redomicile to Texas sets off a broader dialog on governance. The texas stock exchange ceo argues ...
Alphabet is riding a rapid AI infrastructure expansion that could push Google stock toward $500. Cloud revenue is sur...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
Walmart and Costco sit at opposite ends of the retail revenue spectrum, yet their growth stories diverge in meaningfu...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
AI stocks are navigating a choppy market, but marquee names remain firmly in focus for long-term growth. Here’s a tim...
GameStop's Ryan Cohen signals a continued bid to acquire eBay despite board pushback, detailing strategy, financing, ...
As July rolls in, space stocks attract attention—but not all rockets rise equally. This guide spotlights two practica...
Investors can gain exposure to Bill Ackman’s top stocks without buying Pershing Square. A trio of ETFs offers a cost-...